¼¼°èÀÇ µ¶¼º ¾à¹° ½ºÅ©¸®´× ½ÃÀå º¸°í¼­(2025³â)
Toxicology Drug Screening Global Market Report 2025
»óǰÄÚµå : 1769778
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,226,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,000,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,773,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ µ¶¼º ¾à¹° ½ºÅ©¸®´× ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â°£ °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. Àå·¡Àû ¼ºÀå ¿äÀÎÀ¸·Î´Â ¸ÂÃãÇü ÀÇ·á Á¢±Ù¹ýÀÇ ±ÞÁõ, ÀǾàǰÀÇ ¾ÈÀü¼º¿¡ ´ëÇÑ ±ÔÁ¦ÀÇ ÁßÁ¡È­, ´ë¸¶ÃÊ ¹× ÇÕ¼º ¹°ÁúÀÇ »ç¿ë·® Áõ°¡, °³¹ßµµ»ó±¹¿¡¼­ÀÇ ±¤¹üÀ§ÇÑ ÇコÄɾî ÀÎÇÁ¶óÀÇ Á¤ºñ, ¾à¹° ³²¿ëÀÇ ¸¸¿¬ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ÀÌ ±â°£¿¡ ¿¹ÃøµÇ´Â ÁÖ¿ä µ¿Çâ¿¡´Â °í󸮷® ½ºÅ©¸®´× ÅøÀÇ Çõ½Å, µ¶¼ºÇÐ ºÐ¼®¿¡ À־ÀÇ ÀΰøÁö´ÉÀÇ ÀÌ¿ë °­È­, Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î µ¶¼ºÇÐ Áø´ÜÀÇ ÃâÇö, ¹ÙÀÌ¿À ¸¶Ä¿ ÁÖµµÇü ½ºÅ©¸®´× ±â¼úÀÇ Áøº¸, ¾à¹° ½ºÅ©¸®´× ¿öÅ©Ç÷ο쿡 À־ÀÇ ÀÚµ¿È­ ¹× ·Îº¿ ½Ã½ºÅÛÀÇ °³¼±ÀÌ Æ÷ÇԵ˴ϴÙ.

¾à¹° ³²¿ë Áõ°¡´Â µ¶¼º ¾à¹° ½ºÅ©¸®´× ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾à¹° ³²¿ë Áõ°¡´Â ½ºÆ®·¹½º¿Í Á¤½Å À§»ý ¹®Á¦ Áõ°¡·Î ÀÎÇÏ¿© ¸¹Àº »ç¶÷µéÀÌ ´ëó¹ýÀ¸·Î ¾à¹°À» »ç¿ëÇÏ°Ô µÇ¾ú½À´Ï´Ù. 2024³â 8¿ù, National Records of Scotland(NRS)Àº 2023³â ¾à¹° ¿À¿ëÀ¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö¸¦ 1,172¸íÀ¸·Î º¸°íÇß½À´Ï´Ù.

µ¶¼º ¾à¹° ½ºÅ©¸®´× ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ÀÓ»ó, ¹ýÀÇÇÐ, Á÷Àå ȯ°æ¿¡¼­ ¹°Áú °ËÃâÀÇ Á¤È®¼º°ú ¼Óµµ¸¦ Çâ»ó½Ã۱â À§ÇØ ¹ýµ¶¼ºÇÐ ½ºÅ©¸®´×°ú °°Àº Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 6¿ù ¹Ì±¹ »ý¸í°øÇÐ ¹× »ý¸í°úÇбâ¾÷ÀÎ Thermofisher ScientificÀº ÀÓ»ó ¹× ¹ýÀÇÇÐ µ¶¼ºÇÐ ÀÀ¿ë ºÐ¾ß¸¦ À§ÇØ ¼³°èµÈ Á¾ÇÕÀûÀÎ LC-MS(¾×ü Å©·Î¸¶Åä±×·¡ÇÇ Áú·® ºÐ¼®) ½Ã½ºÅÛÀÎ ToxSpec Analyzer¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ¼Ö·ç¼ÇÀº Çϵå¿þ¾î, ¼ÒÇÁÆ®¿þ¾î ¹× °ËÁõ µÈ ¹æ¹ýÀ» °áÇÕÇÏ¿© ¾à¹° ºÐ¼® ½ºÅ©¸®´×À» ÀÚµ¿È­Çϰí ÃÖÀûÈ­ÇÏ¿© LC-MS/MS °æÇèÀÌ Ç³ºÎÇÑ ½ÇÇè½Ç¿¡¼­µµ ÀÌ ±â¼úÀ» Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª¿Í ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Toxicology drug screening is a process designed to detect drugs, chemicals, or their metabolites in biological samples such as urine, blood, saliva, or hair. This type of medical testing is frequently utilized to identify both legal and illegal substances present in a person's system. Its primary purpose is to determine and assess drug exposure in an individual, serving a variety of needs depending on the application context.

Toxicology drug screening encompasses several major types, including monitoring and logging, security, storage, continuous integration or deployment, management and orchestration, networking, data management services, and others. Monitoring and logging refer to the ongoing tracking and documentation of data derived from tests and related activities. This category involves multiple test types such as acute systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, genotoxicity, neurotoxicity, and organ-specific toxicity. It also incorporates advanced technologies like high-throughput screening, genomics, transcriptomics, toxicogenomics, and molecular screening. Applications include immunotoxicity, systemic toxicity, developmental and reproductive toxicity (DART), endocrine disruption, among others. The end users of these screenings span across hospitals, clinics, contract research organizations (CROs), pharmaceutical firms, and workplace drug testing centers.

The toxicology drug screening market research report is one of a series of new reports from The Business Research Company that provides toxicology drug screening market statistics, including toxicology drug screening industry global market size, regional shares, competitors with a toxicology drug screening market share, detailed toxicology drug screening market segments, market trends and opportunities, and any further data you may need to thrive in the toxicology drug screening industry. This toxicology drug screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The toxicology drug screening market size has grown strongly in recent years. It will grow from $19.56 billion in 2024 to $21.44 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The historical growth is driven by increasing instances of drug misuse, the introduction of workplace drug testing regulations, a rise in toxicology testing in athletic settings, the expansion of forensic toxicology capabilities, and the growing use of toxicology analysis in criminal investigations.

The toxicology drug screening market size is expected to see strong growth in the next few years. It will grow to $30.67 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. Contributing factors to this future growth include the surge in personalized medicine approaches, heightened regulatory emphasis on drug safety, an uptick in the usage of cannabis and synthetic substances, broader healthcare infrastructure development in developing countries, and the increasing prevalence of substance abuse. Key trends projected during this period involve innovations in high-throughput screening tools, enhanced use of artificial intelligence in toxicology analytics, the emergence of point-of-care toxicology diagnostics, progress in biomarker-driven screening techniques, and improved automation and robotic systems in drug screening workflows.

The increasing prevalence of drug abuse is anticipated to drive the growth of the toxicology drug screening market. Drug abuse refers to the harmful or excessive consumption of drugs for non-medical purposes, which adversely affects an individual's health and well-being. The rise in drug abuse is attributed to growing stress and mental health issues, prompting many to use substances as a coping mechanism. Toxicology drug screening plays a crucial role in detecting the presence of drugs or their metabolites in the body, facilitating early identification, diagnosis, and monitoring of substance misuse or overdose. For example, in August 2024, the National Records of Scotland (NRS), a government department in Scotland, reported 1,172 drug misuse deaths in 2023, reflecting a 12% increase (121 additional deaths) compared to 2022. As a result, the rising incidence of drug abuse is contributing to the expansion of the toxicology drug screening market.

Leading companies in the toxicology drug screening market are introducing innovative solutions such as forensic toxicology screening to improve the accuracy and speed of substance detection in clinical, forensic, and workplace environments. Forensic toxicology screening involves the examination of biological samples to identify drugs, poisons, or toxins associated with criminal investigations, accidents, or fatalities. For instance, in June 2022, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences firm, launched the ToxSpec Analyzer, a comprehensive LC-MS (liquid chromatography-mass spectrometry) system designed for clinical and forensic toxicology applications. This solution combines hardware, software, and validated methods to automate and optimize drug analyte screening, making the technology accessible even to labs with limited experience in LC-MS/MS. The ToxSpec Analyzer enhances operational efficiency, boosts identification accuracy, and allows laboratories to add new compounds as needed.

In September 2024, Scantox Group, a preclinical contract research organization based in Denmark that specializes in toxicology testing, acquired Gentronix for an undisclosed sum. The acquisition is intended to strengthen Scantox Group's early toxicity testing capabilities by incorporating Gentronix's expertise in genetic toxicology and predictive safety evaluation, thereby broadening its services for the pharmaceutical and chemical sectors. Gentronix, headquartered in the UK, is a preclinical contract research organization offering toxicology services, including drug screening.

Major players in the toxicology drug screening market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthineers, BD Bioscience, Quest Diagnostics, ICON plc, Agilent Technologies Inc., Eurofins Scientific SE, Wuxi AppTec, Charles River Laboratories International Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Evotec AG, Promega Corporation, The Jackson Laboratory, Clinical Reference Laboratory Inc., Enzo Life Sciences Inc., Covance Inc., Randox Toxicology, and Alere Inc.

North America was the largest region in the toxicology drug screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in toxicology drug screening report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the toxicology drug screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The toxicology drug screening market consists of revenues earned by entities by providing services, such as pre-employment drug testing, sports drug testing, confirmatory testing, addiction treatment monitoring, and pain management monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Toxicology Drug Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on toxicology drug screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for toxicology drug screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The toxicology drug screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Toxicology Drug Screening Market Characteristics

3. Toxicology Drug Screening Market Trends And Strategies

4. Toxicology Drug Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Toxicology Drug Screening Growth Analysis And Strategic Analysis Framework

6. Toxicology Drug Screening Market Segmentation

7. Toxicology Drug Screening Market Regional And Country Analysis

8. Asia-Pacific Toxicology Drug Screening Market

9. China Toxicology Drug Screening Market

10. India Toxicology Drug Screening Market

11. Japan Toxicology Drug Screening Market

12. Australia Toxicology Drug Screening Market

13. Indonesia Toxicology Drug Screening Market

14. South Korea Toxicology Drug Screening Market

15. Western Europe Toxicology Drug Screening Market

16. UK Toxicology Drug Screening Market

17. Germany Toxicology Drug Screening Market

18. France Toxicology Drug Screening Market

19. Italy Toxicology Drug Screening Market

20. Spain Toxicology Drug Screening Market

21. Eastern Europe Toxicology Drug Screening Market

22. Russia Toxicology Drug Screening Market

23. North America Toxicology Drug Screening Market

24. USA Toxicology Drug Screening Market

25. Canada Toxicology Drug Screening Market

26. South America Toxicology Drug Screening Market

27. Brazil Toxicology Drug Screening Market

28. Middle East Toxicology Drug Screening Market

29. Africa Toxicology Drug Screening Market

30. Toxicology Drug Screening Market Competitive Landscape And Company Profiles

31. Toxicology Drug Screening Market Other Major And Innovative Companies

32. Global Toxicology Drug Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Toxicology Drug Screening Market

34. Recent Developments In The Toxicology Drug Screening Market

35. Toxicology Drug Screening Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â